Close

Ratings by RBC Capital (Luca Issi)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/6/2023 Graphite Bio Inc GRPH Maintain Sector Perform
(N/A)
 
 
  Details
11/18/2022 Editas Medicine EDIT Maintain Sector Perform
(N/A)
 
 
  Details
11/11/2022 WAVE Life Sciences WVE Maintain Sector Perform
(N/A)
 
 
  Details
11/11/2022 Homology Medicines FIXX Maintain Sector Perform
(N/A)
 
 
  Details
11/11/2022 Adverum Biotechnologies ADVM Maintain Sector Perform
(N/A)
 
 
  Details
11/8/2022 Verve Therapeutics VERV Maintain Outperform
(N/A)
 
 
  Details
11/7/2022 bluebird bio BLUE Maintain Sector Perform
(N/A)
 
 
  Details
11/7/2022 Beam Therapeutics Inc BEAM Maintain Sector Perform
(N/A)
 
 
  Details
11/4/2022 Regenxbio Inc. RGNX Maintain Sector Perform
(N/A)
 
 
  Details
11/4/2022 Intellia Therapeutics NTLA Maintain Outperform
(N/A)
 
 
  Details
11/3/2022 Editas Medicine EDIT Maintain Sector Perform
(N/A)
 
 
  Details
11/2/2022 CRISPR Therapeutics CRSP Maintain Sector Perform
(N/A)
 
 
  Details
10/4/2022 Regenxbio Inc. RGNX Maintain Sector Perform
(N/A)
 
 
  Details
9/20/2022 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
8/12/2022 Adverum Biotechnologies ADVM Maintain Sector Perform
(N/A)
 
 
  Details
8/5/2022 bluebird bio BLUE Maintain Sector Perform
(N/A)
 
 
  Details
8/4/2022 Intellia Therapeutics NTLA Maintain Outperform
(N/A)
 
 
  Details
8/4/2022 Regenxbio Inc. RGNX Maintain Sector Perform
(N/A)
 
 
  Details
5/13/2022 Caribou Biosciences Inc. CRBU Maintain Outperform
(N/A)
 
 
  Details
5/10/2022 CRISPR Therapeutics CRSP Maintain Sector Perform
(N/A)
 
 
  Details
5/3/2022 Sangamo BioSciences SGMO Maintain Outperform
(N/A)
 
 
  Details
5/3/2022 Sangamo BioSciences SGMO Maintain Outperform
(N/A)
 
 
  Details
2/22/2022 Homology Medicines FIXX Downgrade Sector Perform
(Outperform)
3.86
(1.70)
-55.96% Details
2/18/2022 Graphite Bio Inc GRPH New Coverage Sector Perform
(N/A)
11.02
(2.12)
-80.76% Details
2/18/2022 Caribou Biosciences Inc. CRBU New Coverage Outperform
(N/A)
11.37
(7.36)
-35.27% Details
2/18/2022 Verve Therapeutics VERV New Coverage Outperform
(N/A)
30.21
(22.56)
-25.32% Details
2/16/2022 CRISPR Therapeutics CRSP Maintain Sector Perform
(N/A)
 
 
  Details
12/14/2021 Allogene ALLO Maintain Outperform
(N/A)
 
 
  Details
12/8/2021 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
11/22/2021 Alnylam Pharmaceuticals ALNY Upgrade Outperform
(Sector Perform)
178.98
(233.03)
30.2% Details
11/19/2021 Dicerna Pharmaceuticals DRNA Downgrade Sector Perform
(Outperform)
21.28
(38.22)
79.61% Details
11/8/2021 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
11/8/2021 bluebird bio BLUE Maintain Sector Perform
(N/A)
 
 
  Details
10/11/2021 Regenxbio Inc. RGNX Maintain Sector Perform
(N/A)
 
 
  Details
10/8/2021 Allogene ALLO Maintain Outperform
(N/A)
 
 
  Details
10/7/2021 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
9/14/2021 Regenxbio Inc. RGNX Maintain Sector Perform
(N/A)
 
 
  Details
8/10/2021 bluebird bio BLUE Maintain Sector Perform
(N/A)
 
 
  Details
8/6/2021 Dicerna Pharmaceuticals DRNA Maintain Outperform
(N/A)
 
 
  Details
7/2/2021 Arrowhead Pharma ARWR Maintain Outperform
(N/A)
 
 
  Details
6/29/2021 Intellia Therapeutics NTLA Maintain Outperform
(N/A)
 
 
  Details
5/4/2021 Intellia Therapeutics NTLA New Coverage Outperform
(N/A)
76.77
(43.67)
-43.12% Details
5/4/2021 Beam Inc BEAM New Coverage Sector Perform
(N/A)
82.00
(48.11)
-41.33% Details
5/4/2021 Editas Medicine EDIT New Coverage Sector Perform
(N/A)
37.01
(11.17)
-69.82% Details
5/4/2021 Sangamo BioSciences SGMO New Coverage Outperform
(N/A)
11.78
(3.54)
-69.95% Details
4/29/2021 Adverum Biotechnologies ADVM Downgrade Sector Perform
(Outperform)
10.16
(0.69)
-93.21% Details
4/20/2021 CRISPR Therapeutics CRSP Maintain Sector Perform
(N/A)
 
 
  Details
3/30/2021 WAVE Life Sciences WVE Maintain Sector Perform
(N/A)
 
 
  Details
3/29/2021 bluebird bio BLUE Maintain Sector Perform
(N/A)
 
 
  Details
3/23/2021 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
3/23/2021 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
2/25/2021 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
1/28/2021 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
1/20/2021 Regenxbio Inc. RGNX Maintain Sector Perform
(N/A)
 
 
  Details
11/24/2020 Arrowhead Pharma ARWR Maintain Outperform
(N/A)
 
 
  Details
10/23/2020 uniQure BV QURE New Coverage Outperform
(N/A)
39.50
(22.46)
-43.14% Details
10/23/2020 Allogene ALLO Maintain Outperform
(N/A)
 
 
  Details
9/1/2020 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
6/16/2020 Adverum Biotechnologies ADVM Maintain Outperform
(N/A)
 
 
  Details
5/13/2020 Regenxbio Inc. RGNX New Coverage Sector Perform
(N/A)
41.38
(23.28)
-43.74% Details
5/13/2020 Homology Medicines FIXX New Coverage Outperform
(N/A)
13.49
(1.70)
-87.4% Details
5/13/2020 Dicerna Pharmaceuticals DRNA New Coverage Outperform
(N/A)
24.35
(38.22)
56.96% Details
5/13/2020 Adverum Biotechnologies ADVM New Coverage Outperform
(N/A)
19.80
(10.16)
-48.69% Details
5/13/2020 bluebird bio BLUE New Coverage Outperform
(N/A)
60.23
(6.64)
-88.98% Details
5/13/2020 Arrowhead Research ARWR New Coverage Outperform
(N/A)
36.30
(33.37)
-8.07% Details
5/13/2020 Ionis Pharmaceuticals IONS New Coverage Outperform
(N/A)
56.18
(40.74)
-27.48% Details
5/13/2020 Alnylam Pharmaceuticals ALNY New Coverage Sector Perform
(N/A)
142.43
(233.03)
63.61% Details
10/23/0003 CRISPR Therapeutics CRSP New Coverage Sector Perform
(N/A)
92.22
(55.80)
-39.49% Details
10/23/0003 WAVE Life Sciences WVE New Coverage Sector Perform
(N/A)
8.21
(5.09)
-38% Details